Gemphire Therapeutics to Present Corporate Overview at the Ladenburg Thalmann 2016 Healthcare Conference
September 22, 2016 06:00 ET
|
Gemphire Therapeutics
LIVONIA, Mich., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (Nasdaq:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the...
Gemphire Therapeutics Announces Publication of Phase 2 Data for Gemcabene in the Journal of Clinical Lipidology
September 19, 2016 06:00 ET
|
Gemphire Therapeutics
LIVONIA, Mich., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (Nasdaq:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the...
Gemphire Therapeutics Announces Closing of Initial Public Offering
August 10, 2016 16:05 ET
|
Gemphire Therapeutics
NORTHVILLE, Mich., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (Nasdaq:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...
Gemphire Therapeutics Announces Pricing of Initial Public Offering
August 04, 2016 17:57 ET
|
Gemphire Therapeutics
NORTHVILLE, Mich., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of...